TGFB1 and neoplasm: Interfering with TGF-β signaling on various levels, including inhibition of TGF-β receptor kinase with SM16 [61] or inhibition of Smad3 with its inhibitor SIS3 [262] promoted neutrophil anti-tumor polarization.